Literature DB >> 9300797

Structure-activity relationships of P-glycoprotein interacting drugs: kinetic characterization of their effects on ATPase activity.

T Litman1, T Zeuthen, T Skovsgaard, W D Stein.   

Abstract

We have determined the kinetic parameters for stimulation and inhibition by 34 drugs of the P-glycoprotein ATPase in membranes derived from CR1R12 Chinese hamster ovary cells. The drugs chosen were sets of calmodulin antagonists, steroids, hydrophobic cations, hydrophobic peptides, chemotherapeutic substrates of P-glycoprotein, and some other drugs with lower affinity for P-glycoprotein. We studied how these kinetic parameters correlated with the partition coefficient and the Van der Waals surface area of the drugs. The maximum velocity of ATPase stimulation decreased with surface area and showed a suggestion of a maximum with increasing partition coefficient. The affinity of these drugs for P-glycoprotein showed no significant correlation with partition coefficient but was highly correlated with the surface area suggesting that binding between modulators and P-glycoprotein takes place across a wide interaction surface on the protein.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9300797     DOI: 10.1016/s0925-4439(97)00026-4

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  39 in total

1.  P-glycoprotein-ATPase modulation: the molecular mechanisms.

Authors:  Xiaochun Li-Blatter; Andreas Beck; Anna Seelig
Journal:  Biophys J       Date:  2012-03-20       Impact factor: 4.033

2.  Exploring the P-glycoprotein binding cavity with polyoxyethylene alkyl ethers.

Authors:  Xiaochun Li-Blatter; Anna Seelig
Journal:  Biophys J       Date:  2010-12-01       Impact factor: 4.033

3.  Computational predictive models for P-glycoprotein inhibition of in-house chalcone derivatives and drug-bank compounds.

Authors:  Trieu-Du Ngo; Thanh-Dao Tran; Minh-Tri Le; Khac-Minh Thai
Journal:  Mol Divers       Date:  2016-07-18       Impact factor: 2.943

4.  Differential involvement of P-glycoprotein (ABCB1) in permeability, tissue distribution, and antinociceptive activity of methadone, buprenorphine, and diprenorphine: in vitro and in vivo evaluation.

Authors:  Hazem E Hassan; Alan L Myers; Andrew Coop; Natalie D Eddington
Journal:  J Pharm Sci       Date:  2009-12       Impact factor: 3.534

Review 5.  Modeling kinetics of subcellular disposition of chemicals.

Authors:  Stefan Balaz
Journal:  Chem Rev       Date:  2009-05       Impact factor: 60.622

6.  QSAR modeling of the blood-brain barrier permeability for diverse organic compounds.

Authors:  Liying Zhang; Hao Zhu; Tudor I Oprea; Alexander Golbraikh; Alexander Tropsha
Journal:  Pharm Res       Date:  2008-06-14       Impact factor: 4.200

7.  Interaction of verapamil with lipid membranes and P-glycoprotein: connecting thermodynamics and membrane structure with functional activity.

Authors:  M Meier; X Li Blatter; A Seelig; J Seelig
Journal:  Biophys J       Date:  2006-07-28       Impact factor: 4.033

8.  Differential Coupling of Binding, ATP Hydrolysis, and Transport of Fluorescent Probes with P-Glycoprotein in Lipid Nanodiscs.

Authors:  Mavis Jiarong Li; Abhinav Nath; William M Atkins
Journal:  Biochemistry       Date:  2017-05-04       Impact factor: 3.162

9.  Evidence for modulatory sites at the lipid-protein interface of the human multidrug transporter P-glycoprotein.

Authors:  Debjani Mandal; Karobi Moitra; Debabrata Ghosh; Di Xia; Saibal Dey
Journal:  Biochemistry       Date:  2012-03-22       Impact factor: 3.162

10.  Vinblastine 20' Amides: Synthetic Analogues That Maintain or Improve Potency and Simultaneously Overcome Pgp-Derived Efflux and Resistance.

Authors:  John C Lukesh; Daniel W Carney; Huijun Dong; R Matthew Cross; Vyom Shukla; Katharine K Duncan; Shouliang Yang; Daniel M Brody; Manuela M Brütsch; Aleksandar Radakovic; Dale L Boger
Journal:  J Med Chem       Date:  2017-08-31       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.